Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Access of TMC125 in treatment-experienced HIV-1 infected subjects
2006-002499-16Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of etravirine in Human immunodeficiency virus infection type 1, sponsored by Janssen Pharmaceutical. Primary endpoint: Primary safety and tolerability objective. Started Aug 2006; status: completed.
02
Drugs
etravirine
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2006-002499-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002499-16.